These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 59103)

  • 1. Letter: Factor-VIII inhibitor bypassing activity.
    Pollock A; Lewis MJ
    Lancet; 1976 Jul; 2(7975):43-4. PubMed ID: 59103
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
    Parry DH; Bloom AL
    J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
    Tourbaf KD; Dunlap BE; Ambrus JL; Rodman DJ; Atwal AJ
    J Med; 1982; 13(5-6):399-410. PubMed ID: 6820380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of immuninhibitor hemophilia A with FEIBA plasma fraction].
    István L; Bariska I; Marton E
    Orv Hetil; 1980 Dec; 121(51):3131-5. PubMed ID: 6784062
    [No Abstract]   [Full Text] [Related]  

  • 6. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
    Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 8. Total dental extraction in a patient with F VIII inhibitor.
    Stenbjerg S; Tauris P; Skottun T; Jørgensen J
    Thromb Res; 1980 Jun; 18(6):889-93. PubMed ID: 6774444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibitor hemophilia in oral surgery].
    Schulz S
    Zahn Mund Kieferheilkd Zentralbl; 1984; 72(8):824-8. PubMed ID: 6240865
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to activated F IX concentrate (FEIBA).
    Stenbjerg S; Jorgensen J
    Scand J Haematol; 1977 May; 18(5):421-6. PubMed ID: 877518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
    Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
    Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of FEIBA and Amicar in the operating room--dental treatment of a patient with hemophilia and high titer factor VIII inhibitors.
    Sharp HK; McIlveen LP; Schuman NJ
    Spec Care Dentist; 1986; 6(5):210-2. PubMed ID: 2945270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].
    Iizuka A; Kuwashima M; Nagao T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):987-92. PubMed ID: 6818811
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment of hemophilia with minimal doses of factor VIII or factor IX.
    Ripa T; Scaraggi FA; Ciavarella N
    Blood; 1978 Apr; 51(4):763. PubMed ID: 630121
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Prothrombin complex to treat factor VIII inhibition.
    Tishkoff GH
    N Engl J Med; 1975 Apr; 292(14):754-5. PubMed ID: 1113790
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Concentrates of clotting-factor IX.
    Mannucci PM; Bader R; Ruggeri ZM
    Lancet; 1976 Jan; 1(7949):41. PubMed ID: 54544
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-factor VIII anamnesis after factor IX complex.
    Palascak JE; Shapiro SR
    N Engl J Med; 1977 Dec; 297(25):1403. PubMed ID: 927458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.